Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Raje

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Leukemia|February 19, 2013
Lenalidomide in combination with an activin A-neutralizing antibody: preclinical rationale for a novel anti-myeloma strategyT Scullen, L Santo, S Vallet, et al.
Journal of Immunological Methods|February 17, 2000
Isolation and characterization of human multiple myeloma cell enriched populationsY T Tai, G Teoh, Y Shima, et al.
Oncogene|October 4, 2006
A novel Bcl-2/Bcl-X(L)/Bcl-w inhibitor ABT-737 as therapy in multiple myelomaD Chauhan, M Velankar, M Brahmandam, et al.
Medical Oncology (Northwood, London, England)|January 10, 2002
The implication of compromised renal function at presentation in myeloma: similar outcome in patients who receive high-dose therapy: a single-center study of 251 previously untreated patientsB Sirohi, R Powles, J Mehta, et al.
Cancer Research|March 30, 1999
Functional interaction between retinoblastoma protein and stress-activated protein kinase in multiple myeloma cellsD Chauhan, T Hideshima, S Treon, et al.
The Journal of the Association of Physicians of India|July 1, 1995
Evaluating efficiency of bone marrow harvest and its manipulation--role of CD 34 positivityP M Parikh, Y Badrinath, S Dhond, et al.
Bone Marrow Transplantation|October 6, 1997
Outcome assessment of a population-based group of 195 unselected myeloma patients under 70 years of age offered intensive treatmentR Powles, N Raje, S Milan, et al.
Oncogene|December 22, 1999
RAFTK/PYK2-dependent and -independent apoptosis in multiple myeloma cellsD Chauhan, T Hideshima, P Pandey, et al.
Blood|January 29, 2000
CD40 activation mediates p53-dependent cell cycle regulation in human multiple myeloma cell linesG Teoh, Y T Tai, M Urashima, et al.
Blood|February 25, 1999
Bone marrow and peripheral blood dendritic cells from patients with multiple myeloma are phenotypically and functionally normal despite the detection of Kaposi's sarcoma herpesvirus gene sequencesN Raje, J Gong, D Chauhan, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Leukemia|February 19, 2013
Lenalidomide in combination with an activin A-neutralizing antibody: preclinical rationale for a novel anti-myeloma strategyT Scullen, L Santo, S Vallet, et al.
Journal of Immunological Methods|February 17, 2000
Isolation and characterization of human multiple myeloma cell enriched populationsY T Tai, G Teoh, Y Shima, et al.
Oncogene|October 4, 2006
A novel Bcl-2/Bcl-X(L)/Bcl-w inhibitor ABT-737 as therapy in multiple myelomaD Chauhan, M Velankar, M Brahmandam, et al.
Medical Oncology (Northwood, London, England)|January 10, 2002
The implication of compromised renal function at presentation in myeloma: similar outcome in patients who receive high-dose therapy: a single-center study of 251 previously untreated patientsB Sirohi, R Powles, J Mehta, et al.
Cancer Research|March 30, 1999
Functional interaction between retinoblastoma protein and stress-activated protein kinase in multiple myeloma cellsD Chauhan, T Hideshima, S Treon, et al.
The Journal of the Association of Physicians of India|July 1, 1995
Evaluating efficiency of bone marrow harvest and its manipulation--role of CD 34 positivityP M Parikh, Y Badrinath, S Dhond, et al.
Bone Marrow Transplantation|October 6, 1997
Outcome assessment of a population-based group of 195 unselected myeloma patients under 70 years of age offered intensive treatmentR Powles, N Raje, S Milan, et al.
Oncogene|December 22, 1999
RAFTK/PYK2-dependent and -independent apoptosis in multiple myeloma cellsD Chauhan, T Hideshima, P Pandey, et al.
Blood|January 29, 2000
CD40 activation mediates p53-dependent cell cycle regulation in human multiple myeloma cell linesG Teoh, Y T Tai, M Urashima, et al.
Blood|February 25, 1999
Bone marrow and peripheral blood dendritic cells from patients with multiple myeloma are phenotypically and functionally normal despite the detection of Kaposi's sarcoma herpesvirus gene sequencesN Raje, J Gong, D Chauhan, et al.
Pageof 6